IRADIMED CORPORATION (IRMD) — Stock Score Summary

IRADIMED CORPORATION (IRMD) has a MoatMap StockRank of 79/100 based on Quality (82/100), Value (16/100), and Momentum (65/100) factor scores. The current signal is BUY. Iradimed is a high-quality medical device manufacturer with a strong niche moat in MRI-compatible products. However, it lacks direct alignment with our 18-month macro themes, and its high valuation leaves little margin of safety.

IRADIMED CORPORATION is a pioneer and market leader in the development of non-magnetic intravenous (IV) infusion pumps and patient monitoring systems designed for use in MRI environments. The company's competitive moat is its proprietary, non-magnetic technology, which eliminates the safety hazards of standard medical devices near powerful MRI magnets. It operates as a highly specialized, high-margin medical device manufacturer with a near-monopoly in its niche.

Key Financial Metrics

Price$96.42
Market Cap$1.2B
P/E (TTM)51.13
P/E (Forward)39.73
Price/Book12.14
Return on Equity25.0%
Return on Invested Capital26.5%
Gross Margin76.8%
Operating Margin32.9%
Revenue Growth12.6%
Dividend Yield0.9%
Free Cash Flow$15M

IRADIMED CORPORATION operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is IRADIMED CORPORATION’s (IRMD) StockRank?
MoatMap’s StockRank for IRADIMED CORPORATION (IRMD) is 79/100, with a Buy signal. It is a composite of Quality (82), Value (16), and Momentum (65) factor ranks across MoatMap’s 19,000+ stock universe.
Does IRADIMED CORPORATION have an economic moat?
IRADIMED CORPORATION (IRMD) has a Quality factor score of 82/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is IRADIMED CORPORATION a buy, hold, or sell?
MoatMap’s current signal for IRADIMED CORPORATION (IRMD) is Buy, based on a StockRank of 79/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is IRADIMED CORPORATION in?
IRADIMED CORPORATION (IRMD) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksIRMD deep dive reportAI ChampionsHow we score stocksSense-check another stock